Literature DB >> 17276258

Quality of vision with the Acri. Twin asymmetric diffractive bifocal intraocular lens system.

José F Alfonso1, Luis Fernández-Vega, Ana Señaris, Robert Montés-Micó.   

Abstract

PURPOSE: To assess the quality of vision in patients who had implantation of asymmetric Acri. Twin bifocal diffractive intraocular lenses (IOLs) by evaluating distance and near visual acuities and photopic and mesopic contrast sensitivity under monocular and binocular conditions.
SETTING: Fernández-Vega Ophthalmological Institute, Oviedo, Spain.
METHODS: The study comprised 343 consecutive patients who had bilateral implantation of the Acri. Twin system: a distance-weighted 737D IOL and a near-weighted 733D IOL. Monocular and binocular best corrected distance visual acuities, best distance corrected near visual acuity, and distance contrast sensitivity under photopic (85 cd/m(2)) and mesopic (5 cd/m(2)) conditions were determined.
RESULTS: Eyes with the 737D IOL had better best corrected distance acuity than eyes with the 733D IOL (mean 0.036 +/- 0.061 logMAR versus 0.141 +/- 0.131 logMAR) (P<.0001). Eyes with the 733D IOL had better best distance corrected near acuity than eyes with the 737D IOL (mean 0.015 +/- 0.115 logMAR versus 0.059 +/- 0.091 logMAR) (P = .0027). Binocularly, the Acri. Twin system allowed good distance and near vision; the means were 0.031 +/- 0.059 logMAR and 0.005 +/- 0.024 logMAR, respectively. Contrast sensitivity with the Acri. Twin system was within normal limits under photopic and mesopic conditions. Contrast sensitivity was statistically significantly better with the Acri. Twin system, followed by the 737D IOL and the 733D IOL under both illumination levels.
CONCLUSIONS: Asymmetric bilateral implantation of the Acri. Twin IOL gave good simultaneous distance and near vision with improved contrast sensitivity under photopic and mesopic conditions. Differences between monocular and binocular visual acuity and contrast sensitivity were obtained because of the distance-/near-weighted light distribution of Acri. Twin IOLs.

Entities:  

Mesh:

Year:  2007        PMID: 17276258     DOI: 10.1016/j.jcrs.2006.09.033

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  7 in total

1.  Refractive lens exchange with distance-dominant diffractive bifocal intraocular lens implantation.

Authors:  José F Alfonso; Luis Fernández-Vega; Susana Ortí; Robert Montés-Micó
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-03-16       Impact factor: 3.117

Review 2.  [Use of multifocal intraocular lenses and criteria for patient selection].

Authors:  T Kohnen; D Kook; G U Auffarth; V Derhartunian
Journal:  Ophthalmologe       Date:  2008-06       Impact factor: 1.059

Review 3.  [Design and optical principles of multifocal lenses].

Authors:  G U Auffarth; T M Rabsilber; T Kohnen; M P Holzer
Journal:  Ophthalmologe       Date:  2008-06       Impact factor: 1.059

4.  Comparison of visual outcomes, spectacles dependence and patient satisfaction of multifocal and accommodative intraocular lenses: innovative perspectives for maximal refractive-oriented cataract surgery.

Authors:  Raffaele Nuzzi; Federico Tridico
Journal:  BMC Ophthalmol       Date:  2017-02-14       Impact factor: 2.209

5.  Visual And Refractive Outcomes In Hyperopic Pseudophakic Patients Implanted With A Trifocal Intraocular Lens.

Authors:  José F Alfonso; Andrés Fernández-Vega-Cueto; Belén Alfonso-Bartolozzi; Ignacio Rodríguez-Uña; Robert Montés-Micó
Journal:  Clin Ophthalmol       Date:  2019-11-20

6.  Medium-term visual outcomes of apodized diffractive multifocal intraocular lens with +3.00 d addition power.

Authors:  Xiaohong Guo; Yi Sun; Bowen Zhang; Danying Zheng
Journal:  J Ophthalmol       Date:  2014-03-03       Impact factor: 1.909

7.  Comparative Analysis of Visual Performance and Optical Quality with a Rotationally Asymmetric Multifocal Intraocular Lens and an Apodized Diffractive Multifocal Intraocular Lens.

Authors:  Xiao Wang; Haixia Tu; Yong Wang
Journal:  J Ophthalmol       Date:  2020-04-20       Impact factor: 1.909

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.